Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Notes Payables: 2020-2024

  • iSpecimen's Notes Payables was N/A to $864,425 in Q3 2024 from the same period last year, while for Sep 2024 it was $864,425, marking a year-over-year change of. This contributed to the annual value of $604,109 for FY2020, which is N/A change from last year.
  • Per iSpecimen's latest filing, its Notes Payables stood at $864,425 for Q3 2024, which was up 5.85% from $816,667 recorded in Q3 2022.
  • iSpecimen's 5-year Notes Payables high stood at $864,425 for Q3 2024, and its period low was $466,667 during Q2 2022.
  • Its 2-year average for Notes Payables is $715,920, with a median of $816,667 in 2022.